Jim Simons acquired 2.59 Million Precision Biosciences shares worth $27.2 Million. That's 0.04% of their equity portfolio (484th largest holding). The investor owns 40.40% of the outstanding Precision Biosciences stock. The first Precision Biosciences trade was made in Q1 2020. Since then Jim Simons bought shares eight more times and sold shares on six occasions. The stake costed the investor $3.84 Million, netting the investor a gain of 607% so far.